Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

For the first time since 2000, the U.S. has lost its measles elimination status, with over 5,400 cases in 2026 alone — more than double last year's total — and at least 13 measles-associated deaths. Declining childhood vaccination rates, vaccine misinformation, and limited healthcare access have fueled the crisis. Experts say bringing MMR vaccines into community spaces and improving testing access are the clearest paths to reclaiming elimination status.
For the first time in 25 years, the U.S. has officially lost its measles elimination status. The Pan American Health Organization (PAHO) confirmed this week that measles has reestablished regular transmission in the country — a designation that requires outbreaks to stop spreading within a year, which is no longer happening. Over 5,400 cases have been reported in 2026 alone, more than double the 2025 total, with at least 13 measles-associated deaths including infants in New York, Wisconsin, and Pennsylvania.
The root cause is straightforward: declining MMR vaccination rates. Only 10 states hit the 95% coverage threshold needed for herd immunity in the 2025–2026 school year. Public health experts point to a combination of COVID-era disruptions to routine childhood immunization, the spread of vaccine misinformation, and cuts to immunization programs as key drivers. Meanwhile, a newly developed rapid measles test — capable of diagnosing hundreds of cases within 8 hours — remains unavailable after the CDC failed to validate it.
By the Numbers:
Why it matters: Losing elimination status isn't just symbolic — it signals that measles may be gaining a foothold in the U.S. Regaining that status will require expanding vaccine access into pharmacies, schools, and community centers, restoring public trust in immunization, and ensuring rapid diagnostic tools are available nationwide.